These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Experience of immunotherapy with leukinferon in the comprehensive therapy of breast cancer]. Korobkova LI; Kuznetsov VP; Rasskazchikova ES; Beliaev DL; Vel'sher LZ; Babadiants AA; Zverev MP; Strekalovskiĭ SV; Zueva LA Vopr Onkol; 1994; 40(7-12):309-13. PubMed ID: 7610626 [TBL] [Abstract][Full Text] [Related]
5. [The use of leukinferon in treating zoonotic cutaneous leishmaniasis. 1. Research on an experimental model in mice]. Shuĭkina EE; Sergiev VP; Kuznetsov VP; Beliaev DL; Fediainova IE Med Parazitol (Mosk); 1993; (2):28-31. PubMed ID: 8028564 [TBL] [Abstract][Full Text] [Related]
7. [Approaches to the combined therapy of helminthiases with leukinferon and etiotropic preparations]. Lebedeva MN; Malysheva NS; Fedianina LV; Shuĭkina EE; Gitsu GA Med Parazitol (Mosk); 1998; (1):15-7. PubMed ID: 9608202 [TBL] [Abstract][Full Text] [Related]
8. [The clinico-immunological effects of leukinferon in the treatment of patients with acute suppurative pyelonephritis]. Vozianov AS; Kuznetsova VP; Driianskaia VE; Pasechnikov SP; Ozvinchuk II; Musiĭ MIa; Fedorchuk GV; Beliaev DL; Dranik GN Urol Nefrol (Mosk); 1994; (3):8-11. PubMed ID: 8079417 [TBL] [Abstract][Full Text] [Related]
9. [The clinical efficacy in using leukinferon in adults with diseases caused by the varicella-zoster virus]. Kuznetsov VP; Nikolaeva IN; Barer GM; Beliaev DL; Sundukov AV; Babaiants AA; Iushchuk ND Zh Mikrobiol Epidemiol Immunobiol; 1995; (4):72-5. PubMed ID: 9381878 [TBL] [Abstract][Full Text] [Related]